{"id":"https://openalex.org/W2337565256","doi":"https://doi.org/10.1016/j.jalz.2015.07.367","title":"O4\u201004\u201005: Aducanumab (BIIB037), an anti\u2010amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double\u2010blind, placebo\u2010controlled, phase 1b study","display_name":"O4\u201004\u201005: Aducanumab (BIIB037), an anti\u2010amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double\u2010blind, placebo\u2010controlled, phase 1b study","alternate_titles":[],"publication_year":2015,"publication_date":"2015-07-01","ids":{"openalex":"https://openalex.org/W2337565256","doi":"https://doi.org/10.1016/j.jalz.2015.07.367","mag":"2337565256"},"language":"en","primary_location":{"id":"doi:10.1016/j.jalz.2015.07.367","doi":"https://doi.org/10.1016/j.jalz.2015.07.367","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2015.07.367","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2337565256"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108511453","display_name":"Jeff Sevigny","orcid":"https://orcid.org/0000-0003-0974-6434","observed_orcids":["https://orcid.org/0000-0003-0974-6434"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jeff Sevigny","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108511454","display_name":"Ping Chiao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ping Chiao","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102985092","display_name":"Leslie J. Williams","orcid":"https://orcid.org/0000-0003-4056-7979","observed_orcids":["https://orcid.org/0000-0003-4056-7979","https://orcid.org/0000-0003-4054-1074"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Leslie Williams","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088531741","display_name":"Tianle Chen","orcid":"https://orcid.org/0009-0000-5930-0145","observed_orcids":["https://orcid.org/0009-0000-5930-0145"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tianle Chen","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yan Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yan Ling","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":null,"display_name":"John O'Gorman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John O'Gorman","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110956934","display_name":"Christoph H\u00f6ck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christoph Hock","raw_affiliation_strings":["Neurimmune Holding AG, Zurich, Switzerland","University of Zurich, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurimmune Holding AG, Zurich, Switzerland","institution_ids":[]},{"raw_affiliation_string":"University of Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109156775","display_name":"Roger M. Nitsch","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I202697423","display_name":"University of Zurich","ror":"https://ror.org/02crff812","country_code":"CH","type":"education","lineage":["https://openalex.org/I202697423"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger M. Nitsch","raw_affiliation_strings":["Neurimmune Holding AG, Zurich, Switzerland","University of Zurich, Zurich, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurimmune Holding AG, Zurich, Switzerland","institution_ids":[]},{"raw_affiliation_string":"University of Zurich, Zurich, Switzerland","institution_ids":["https://openalex.org/I202697423"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111831588","display_name":"Alfred W. Sandrock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alfred Sandrock","raw_affiliation_strings":["Biogen Idec Inc, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec Inc, Cambridge, MA, USA","institution_ids":["https://openalex.org/I1297540436"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5108511453"],"corresponding_institution_ids":["https://openalex.org/I1297540436"],"apc_list":{"value":4200,"currency":"USD","value_usd":4200},"apc_paid":null,"fwci":3.0201,"has_fulltext":false,"cited_by_count":46,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91934022,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"11","issue":"7S_Part_6","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aducanumab","display_name":"aducanumab","score":0.9909999966621399}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.9101098775863647},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.73409104347229},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6783699989318848},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6472877860069275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.559668242931366},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.5048235058784485},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.48238125443458557},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.407928466796875},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3651387393474579},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.26716071367263794},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.1983027160167694},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jalz.2015.07.367","doi":"https://doi.org/10.1016/j.jalz.2015.07.367","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.jalz.2015.07.367","pdf_url":null,"source":{"id":"https://openalex.org/S108427512","display_name":"Alzheimer s & Dementia","issn_l":"1552-5260","issn":["1552-5260","1552-5279"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-3","ki-jl-3","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Alzheimer's &amp; Dementia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2203769893","https://openalex.org/W2558965465","https://openalex.org/W2466890096","https://openalex.org/W2808356172","https://openalex.org/W2765969262","https://openalex.org/W2511078294","https://openalex.org/W2803651213","https://openalex.org/W2536455927","https://openalex.org/W2767363231","https://openalex.org/W3207108334"],"abstract_inverted_index":{"Aducanumab":[0,210],"(BIIB037)":[1],"is":[2,26],"a":[3,17,60,93],"human":[4],"monoclonal":[5],"antibody":[6],"selective":[7],"for":[8,20,70,89,177,191],"aggregated":[9],"forms":[10],"of":[11,34,102],"beta-amyloid":[12,128,212],"peptide":[13],"being":[14],"investigated":[15],"as":[16],"disease-modifying":[18],"treatment":[19,104],"AD.":[21,42,74,220],"This":[22],"Phase":[23],"1b":[24],"study":[25,52],"evaluating":[27],"the":[28,76,141,160,172,204],"safety,":[29],"tolerability,":[30],"pharmacokinetics,":[31],"and":[32,66,115,164,181,207],"pharmacodynamics":[33],"aducanumab":[35,82,184],"in":[36,45,126,155,167,214,226],"patients":[37,80,97,215],"with":[38,216],"prodromal":[39,71,217],"or":[40,72,83,218],"mild":[41,73,219],"Patients":[43],"included":[44,119],"this":[46],"multicenter,":[47],"randomized,":[48],"double-blind,":[49,77],"placebo-controlled,":[50],"multiple-dose":[51],"(PRIME;":[53],"NCT01677572)":[54],"were":[55,98],"aged":[56],"50-90":[57],"years,":[58],"had":[59],"positive":[61],"florbetapir":[62],"(F-AV-45)":[63],"PET":[64,133],"scan,":[65],"met":[67],"clinical":[68,222],"criteria":[69],"During":[75],"placebo-controlled":[78],"phase,":[79],"received":[81],"placebo":[84],"once":[85],"every":[86],"4":[87],"weeks":[88],"52":[90],"weeks.":[91],"In":[92],"staggered,":[94],"ascending-dose":[95],"design,":[96],"randomized":[99],"to":[100,123],"1":[101],"7":[103],"arms":[105,157,169],"stratified":[106],"by":[107,132],"ApoE4":[108],"status":[109],"(carrier/non-carrier).":[110],"Primary":[111],"endpoint":[112],"was":[113,146,203,224],"safety":[114,206],"tolerability.":[116],"Secondary":[117],"endpoints":[118],"change":[120,137],"from":[121,138],"baseline":[122,139],"Week":[124,161,173,186,195],"26":[125,162],"brain":[127],"plaque":[129,213],"burden":[130],"measured":[131],"imaging.":[134],"Cognition/functioning,":[135],"including":[136],"on":[140],"Clinical":[142],"Dementia":[143],"Rating":[144],"scale,":[145],"an":[147],"exploratory":[148,227],"endpoint.":[149],"Interim":[150],"analyses":[151],"included:":[152],"(1)":[153],"subjects":[154,166],"all":[156,168],"who":[158,170],"completed":[159,171],"visit,":[163],"(2)":[165],"54":[174,187,196],"visit":[175],"(results":[176],"placebo,":[178],"1,":[179],"3":[180],"10":[182],"mg/kg":[183,193],"at":[185,194],"available":[188],"here,":[189],"results":[190],"6":[192],"will":[197],"be":[198],"presented).":[199],"Figure":[200],"Dose-dependent":[201],"ARIA":[202],"main":[205],"tolerability":[208],"finding.":[209],"reduced":[211],"A":[221],"signal":[223],"observed":[225],"analysis.":[228]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2337565256","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":13},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
